Background: Strategies to improve mechanical strength, neovascularization, and the regenerative capacity of allograft
T
here is an ever-expanding requirement for bone graft within orthopaedics, with a wide range of indications. The rate of revision hip arthroplasty, which often requires treatment of bone loss, increased threefold between 2003 and 2010 1 . For procedures involving the replacement of large volumes of bone stock, the main source is usually allograft from either cadavera or donors 2, 3 . The beneficial effects of the addition of skeletal stem cells to allograft have been proven via both in vitro and in vivo impaction bone-graft models to improve aggregate shear strength, increase new bone formation, and improve vascularization 4, 5 . This approach has been successfully incorporated into a core decompression technique for the treatment of patients with osteonecrosis of the femoral head, and clinical trials for patients undergoing revision hip surgery involving impaction bone graft are also planned 6, 7 . However, problems related to the use of allograft include cost, rejection, and infective transmission 2, 3, [8] [9] [10] . Tissue-engineered constructs combining skeletal stem cells with biodegradable Disclosure: One or more of the authors received payments or services, either directly or indirectly (i.e., via his or her institution), from a third party in support of an aspect of this work. In addition, one or more of the authors, or his or her institution, has had a financial relationship, in the thirty-six months prior to submission of this work, with an entity in the biomedical arena that could be perceived to influence or have the potential to influence what is written in this work. No author has had any other relationships, or has engaged in any other activities, that could be perceived to influence or have the potential to influence what is written in this work. The complete Disclosures of Potential Conflicts of Interest submitted by authors are always provided with the online version of the article.
polymers have the potential to replace allograft 11 . Recently, skeletal stem cell/polymer composites have been specifically tailored for use in impaction bone-grafting, and both in vitro and in vivo trials have shown encouraging results for potential clinical use 12, 13 . There remain, however, important differences between experimental models and the actual clinical use of tissueengineered materials that need to be carefully addressed prior to the incorporation of novel technologies. A possible pitfall to the successful implementation of tissue-engineered constructs in impaction bone-grafting involves the potential damaging exothermic effects of setting bone cement. The purpose of this study was therefore to investigate the effects of setting bone cement on both a tissue-engineered skeletal stem cell/allograft composite and a novel skeletal stem cell/polymer composite designed for translational use in impaction bone-grafting. A second stage of the experiment entailed investigating methods of possibly reducing the damaging exothermic effects of the cement on the skeletal stem cells.
Materials and Methods
Cell Culture W ith approval of our Local Research Ethics Committee (LREC 194/99/w 27/ 10/10), bone marrow was obtained from fully consenting patients undergoing a routine total hip replacement. The cells used in study 1 were from an eighty-nine-year-old man (M89), and the cells used in study 2 were from a sixty-six-year-old man (M66). Progenitor cells were extracted and then cultureexpanded on standard tissue culture plastic (T150) flasks in basal media (Sigma-Aldrich, Poole, United Kingdom) and incubated at 37°C in 5% CO 2 . On confluence (fourteen days), the cells were released with use of trypsin in ethylene diamine tetra-acetic acid (EDTA; Sigma-Aldrich), combined and suspended in basal media, and centrifuged at 1100 rpm for four minutes, after which the supernatant was discarded. The remaining cell pellet was resuspended in basal media to give a concentration of 5 · 10 5 cells/mL, as determined with a hemocytometer.
Allograft Preparation
Femoral heads were also obtained with patient consent and approval of our Local Research Ethics Committee (LREC 194/99/w 27/10/10) from patients undergoing total hip replacement. Under aseptic conditions in an operating room environment, the cartilage, cortical bone, soft tissue, and cysts were removed, prior to morcellation with a standard bone mill (Noviomagus; Spierings Orthopaedics, Nijmegen, the Netherlands [mean particle size, 2.1 mm 14 ]). The bone was then defatted via repeated immersion in 6% hydrogen peroxide solution, followed by multiple washes in phosphate-buffered saline solution (PBS) and a twenty-four-hour incubation in 5· antibiotic solution under ultraviolet (UV) light to ensure sterility; it was then subjected to an additional twenty-four hours of incubation in basal media.
Polymer Preparation
Previous work performed in our department had identified high-molecularweight poly(DL-lactide) (P DL LA) in combination with 10% hydroxyapatite to have desirable characteristics for potential translation as an allograft alternative in impaction bone-grafting 12 . This material was obtained from Evonik (Birmingham, Alabama), and porous scaffolds were produced with use of a novel supercritical CO 2 foaming technique as detailed previously 15 . These scaffolds were then milled and sterilized in 5· antibiotic solution and twenty-four hours of UV light exposure, followed by another twenty-four hours of incubation in basal media.
Allograft/Polymer Seeding
The basal media were removed from both the milled allograft and the polymer, and the cell suspension was added at a ratio of 1 mL of solution to 1 mL of allograft or polymer. The composites were then incubated for two hours (37°C, 5% CO 2 ) in universal tubes, with gentle agitation every twenty to thirty minutes in order to allow diffuse cell adhesion. For study 1, the seeded allograft or polymer was used immediately for experimentation, as would be the case when it is applied clinically. For the second study, the allograft and polymer were seeded with skeletal stem cells in the same manner; were subsequently transferred to individual wells of six-well plates (approximately 2 to 3 mL of each per well); and were incubated in basal media at 37°C, 5% CO 2 , with standard PBS washes and media changes every three to four days until the cells reached confluence at approximately fourteen days. Cell numbers involved for experimentation were thus higher, and hence any beneficial effects on cell survival of pretreatment methods would be more pronounced and, critically, detectable and quantifiable.
Study 1
A protocol for the methodology used in study 1 is shown in Figure 1 . Sixteen 5-mL syringes were customized such that the tips were removed and markings were made at 0 to 5-cm intervals longitudinally. Eight of these syringes were filled up to the 2-cm mark with skeletal stem cell (M89)-seeded allograft (group 1) and eight, with skeletal stem cell (M89)-seeded polymer (group 2). Cement (Surgical Simplex P; Stryker, Newbury, United Kingdom) was then prepared according to the manufacturer's protocol and was placed in four of the syringes of each group in apposition with the graft prior to setting, such that a cement mantle of 5 mm was created. The thickness of the cement mantle affects the temperatures reached, and 5 mm was deemed to be the upper end of the thickness obtained during impaction bone-grafting 16 .
Thumb pressure was applied to the syringe plungers with an attempt to apply a roughly equal compressive force to the cement against the graft in order to mimic the compression that occurs during cement pressurization (see Appendix). The graft-containing syringes were then placed into a custom-made polystyrene holder, such that the heat from the setting cement was directed toward the skeletal stem cell-seeded graft. The remaining four syringes from each group were used as positive controls. The cement was molded into cylinders, allowed to set and cool, and then placed in apposition with the seeded allograft or polymer (thumb pressure applied), so that the skeletal stem cells were not exposed to the exothermic reaction. The syringes were then submerged in basal media prior to analysis.
Assessment of Cell Viability
WST-1 cell proliferation assay: A WST-1 assay was used as a measure of remaining cell viability after exposure to setting cement. This assay is a measure of total cell metabolic activity and hence its results are closely related to the number of viable cells. After one hour (the time required for the experimental setup), the contents of the syringes were analyzed. The plungers were used to expel the graft in 0.5-cm incremental distances from the cement-graft interface. Each 0.5-cm section was analyzed separately so that the exothermic effects of the cement could be quantified by distance. This provided a range of distances from the cement at which 50% of cells had survived (LD50). Each graft section was submerged in 2 mL of a 1:10-dilution WST-1 substrate (Roche, Welwyn Garden City, United Kingdom). Blank WST-1 samples were run in parallel (negative controls). After four hours, 3 · 100-mL WST-1 substrates were removed from each sample with use of a micropipette (Edu-Lab, Norfolk, United Kingdom) (n = 4 per 0.5-cm increment) and analyzed with a Bio-Tek KC4 microplate fluorescent reader (Bio-Tek, Winooski, Vermont) at 410 nm. An increase in absorbance value (i.e., an increase in the optical density of the substrate) indicated increased cell number and viability. The mean absorbance value was then calculated for both the allograft and the polymer at each 0.5-cm incremental distance from the cement-graft interface, and the mean negativecontrol WST-1 absorbance value was subtracted.
Standard Curve
In order to calculate an LD50 distance, a standard curve for the WST-1 assay was established with use of the same (M89) cell line. Known numbers of cells were seeded into individual wells of a twelve-well plate in 1 mL of basal media. One milliliter of 1:10-dilution WST-1 reagent was added, and 3 · 100 mL of substrate was removed at four hours, and read as described above; the mean absorbance value was then calculated. After subtraction of the negative control value, a change in the absorbance value could be related to a known cell number and hence the distance (in 0.5-cm increments) from the cementgraft interface at which 50% of the cells survived the exposure could be calculated.
Temperature Assessment
A supplemental test was conducted to assess the temperature profile through the graft as a function of the distance from the cement-graft interface. For this test, 2.5-mL syringes were loaded with graft material up to 0.5 cm from the open end, and instrumented with use of K-type thermocouple wires (RS Components; Corby, United Kingdom). Thermocouples were placed to measure the temperature at four locations throughout bonecement curing: i.e., in the cement as well as 0.5 cm, 1.0 cm, and 1.5 cm above the cement-graft interface. Data were recorded with use of a MicroMeasurements 7000 Series Data Acquisition System and StrainSmart software (Vishay Precision Group UK, Basingstoke, United Kingdom), at a sample rate of 10 Hz. The cement was mixed and after two minutes, when it was doughy, it was introduced to fill the remaining 0.5 cm of the syringe and pressed in with light thumb pressure. The syringe was then pressed into a block of expanded polystyrene for thermal isolation, and data were recorded for twenty minutes, at which point a temperature peak associated with cement curing had been recorded by all of thermocouples. The experiment was repeated in triplicate for both the polymer and the allograft specimens.
Study 2
A protocol for the methodology used in study 2 is shown in Figure 2 . Having established the effects of setting bone cement on tissue-engineered constructs, we initiated changes to the pretreatment protocols in an attempt to reduce the toxicity. A modified experiment was designed because of the increase in experimental groups and to keep all graft in close proximity (<1 cm) to the cement-graft interface, after which distance negligible loss of cell viability was observed (established by study 1). Cells were grown to confluence on milled polymer and allograft as described above, before being impacted Diagram displaying the protocol for study 1. SSC = skeletal stem cells.
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into modified electron-microscopy pots (1-mL volume). There were twenty pots in total for the allograft and twenty pots in total for the polymer, and these were subsequently divided into five groups of four pots each. One group was treated as a negative control and was subjected to cold, preset cement only. In a second group, which acted as a positive control, 0.5 mL of mixed cement was added to the electron-microscopy pots (see Appendix), which was pressurized via thumb compression and subsequently allowed to set via its normal exothermic reaction. A third group of four pots acted as the first of the treatment groups. These pots were precooled to 5°C for one hour prior to exposure of the graft to the cement, which was added as described for group 2. In the fourth group, the allograft or polymer was dipped in 1% Laponite (a bioactive clay, made by Rockwood Additives, Widnes, United Kingdom, with the potential for protecting the cells) prior to exposure to the setting cement. In a final group, the pots were cooled to 5°C for one hour and the allograft or polymer was dipped in 1% Laponite prior to cement exposure.
Cell Viability
Live/dead immunostain: Small portions of polymer were taken from the graftcement interface and at a 1-cm distance, in order to illustrate visually the effects of the setting bone cement. Samples were incubated for ninety minutes in 5 mL of standard Cell Tracker Green probe (CTG)/ethidium homodimer (EH-1) solution (10 mg/mL of CTG and 5 mg/mL of EH-1, Invitrogen; Life Technologies, Paisley, United Kingdom). They were then fixed in ethanol and stored in PBS prior to imaging. Images were obtained with use of Carl Zeiss Axiovision Software (version 3.0) via an AxioCam HR digital camera on an Axiovert 200 inverted microscope (Carl Zeiss, Cambridge, United Kingdom) under fluorescent light. WST-1 assay: Cell viability was again tested with use of a WST-1 cell proliferation assay. After one hour of incubation in basal media after cement exposure, the contents of each of the electron-microscopy pots were removed and were placed individually into 1 mL of 1:10-dilution WST-1 substrate (Roche). After four hours of incubation, 3 · 100 mL of substrate was removed and was analyzed with use of a Bio-Tek KC4 microplate fluorescent reader at 410 nm. After subtraction of the blank WST-1 absorbance values, the means and standard deviations for optical densities were calculated for each of the treatment groups.
Statistical Methods
All experimental groups were replicated four times, and statistical comparison was performed with use of one-way analysis of variance (ANOVA) with post hoc Bonferroni analysis. A p value of <0.05 was considered to be significant. 
Source of Funding

Results
Study 1
T he mean cell viability, as measured by an increase in the optical density with use of the WST-1 assay, was observed to increase as the distance from the cement-bone interface increased in both the skeletal stem cell-seeded allograft and the skeletal stem cell-seeded polymer group (see Appendix). The effect was more pronounced in the allograft group, which had a reduction in the mean optical density of 84% (compared with the control group) at a distance of 0 to 0.5 cm from the cement-bone interface and of 48% at a distance of 0.5 to 1.0 cm, although only the reduction at 0 to 0.5 cm was significant (one-way ANOVA, p < 0.01) (Fig. 3) .
When the absorbance values were related to the actual cell numbers via the standard curve (see Appendix), the mean control value (optical density = 0.06) was found to be related to approximately 38,000 cells. In comparison, the value for 0 to 0.5 cm from the cement-graft interface (optical density = 0.01) related to approximately 4000 cells, the value for 0.5 to 1.0 cm from the cement-graft interface (optical density = 0.03) related to approximately 18,000 cells, and that for 1.0 to 1.5 cm Diagram displaying the protocol for study 2. SSC = skeletal stem cells, and EM = electron-microscopy.
739
EFFECTS O F S E T T I N G B O N E CEMENT O N T I S S U E -ENGINEERED B O N E GRAFT
(optical density = 0.07) related to >40,000 cells. There was thus no measurable loss of cells at 1.0 to 1.5 cm compared with the controls; hence, in this experiment, the LD50 distance was observed to lie between 0.5 and 1 cm from the cement-graft interface.
In the polymer group, there was a reduction in the mean optical density (compared with the control group) of 32% at a distance of 0 to 0.5 cm from the cement-bone interface and of 16% at 0.5 to 1.0 cm (Fig. 3) , although these changes were not significant. When absorbance values were related to actual cell numbers (see Appendix), the mean control value (optical density = 0.13) was found to be related to approximately 90,000 cells and the value for 0 to 0.5 cm from the cementgraft interface (optical density = 0.09) related to approximately 59,000 cells. Thus, in this group, the LD50 distance was noted to lie between 0 and 0.5 cm from the cement-graft interface.
Temperature Assessment
A typical graph displaying change in temperature against time for each of the 0.5-cm increments as the cement cured is displayed in the Appendix, and the mean increases in temperature values at these locations are shown in Table I . In keeping with the results of the cellular experiments, there was only a moderate temperature rise (mean and standard deviation, 9.1 ± 3.9°C for the polymer and 8.4 ± 3.8°C for the allograft) at a distance of 0.5 cm from the cement and negligible temperature rises at farther distances.
Study 2
Live/Dead Stain Cell viability was displayed visually by using a standard live/ dead stain. Samples were taken from the cement-graft interface and from 1 cm distal to it. There was a reduction in the density of viable (green-staining) cells at the cement-bone interface and an increase in the number of dead or compromised (red) cells. One centimeter distal to the cement, there was confluent live-cell coverage and very few dead cells (Fig. 4) . 740
EFFECTS O F S E T T I N G B O N E CEMENT O N T I S S U E -ENGINEERED B O N E GRAFT
WST-1 Assay
The mean cell viability, as assessed with use of the WST-1 assay, showed a decrease in all groups when compared with that of the negative control group (subjected to cold preset cement), and this decrease was significant for all of the seeded-allograft groups and in all but the precooled-polymer groups (Figs. 5 and 6; one-way ANOVA, p < 0.05). No significant increase in cell viability was found when any of the treatment groups was compared with the positive control group (hot cement only), indicating that none of the pretreatment protocols effectively protected the cells from the toxic effects of the setting cement. Interestingly, the addition of 1% Laponite actually appeared to significantly reduce cell activity on both the allograft and the polymer, under both the ambient temperature and the precooled conditions (p < 0.01).
Discussion
T he addition of skeletal stem cells to allograft for use in impaction bone-grafting enhances the cohesive strength of the allograft in vitro as well as improves vascularization and bone formation in vivo 4, 17 . However, none of the previous studies on this technique exposed the graft to the exothermic effects of bone cement, a factor used in the majority of clinical cases 18 . In the present in vitro study, we examined the impact of setting bone cement on two skeletal stem cell-seeded constructs, both of which have the potential for clinical use. We demonstrated that there is a loss of cell viability associated with the rise in temperature but it is significant only within 0.5 cm of the cement-graft interface. Only one previous (unpublished) study has, to our knowledge, addressed the question of skeletal-stem-cell heat tolerance; in that study, cell cultures were exposed to media of increasing temperatures for differing time periods 19 . The authors concluded that cells could survive exposure to up to 48°C for 150 seconds but most cells perish when exposed to >58°C for the same incubation period. Our data complement their research but we add a model more consistent with the clinical situation: we used actual bone cement as the toxicant and cell-seeded allograft for the analysis, allowing calculation of a quantitative distance for the harmful effects.
Studies of cadavera of patients who had undergone impaction bone-grafting with use of standard allograft have shown allograft replacement by host bone around the periphery of the construct, but the central areas in close proximity to the cement consisted of necrotic bone and fibrous tissue only 20, 21 . The current study indicates that, despite the addition of skeletal stem cells to any construct, this is still a possibility due to the loss of cell viability in these regions. However, our experiments did demonstrate some measurable cell viability within close proximity (0.5 cm) of the cement-graft interface (especially in the polymer graft substitute), although the viability was reduced. This finding of continued viability indicates that the cellular components of the constructs are not completely destroyed, hence leaving the potential for cell colony recovery via subsequent proliferation of the surviving cells. Temperatures experienced at the bone-cement interface were found to rise to a maximum of 48°C in one study 22 and 56°C in another 23 , both of which temperatures were significantly less than the temperature of the actual cement layer 22, 23 . Reasons cited for this phenomenon include the presence of blood and moisture, the large surface area, and poor heat conductivity of methylmethacrylate. The findings of both our cell study (continued cell viability close to the cement) and our temperature analysis are in keeping with those of these studies.
One limitation of our study involved the estimate of the total cell number and the LD50 distance via the relation to the standard curve. The WST-1 assay is a measure of total cell metabolism; hence, the activity of a known number of cells seeded on tissue culture plastic does not necessarily represent the same cell number in the three-dimensional environment. It is also not known whether the surviving cells' ability to divide or differentiate is affected by the heat exposure. Another limitation includes the fact that the cells from only one donor were used in Graph showing mean optical density values (± SD, n = 4) of WST-1 substrate after four hours of incubation with the pretreated portions of allograft after cement exposure. *P < 0.05 and **p < 0.01, when compared with the cold cement control value. each of the studies, as the heterogeneity of skeletal-stem-cell behavior among patients may also alter these findings.
Actual cement mantle thickness can affect the final temperature obtained during the polymerization process. The authors of a recent finite-element-analysis study attempted to correlate cement mantle thickness to surrounding thermal necrosis of bone, concluding that a 7-mm-thick mantle (thicker than that used in most standard practice) was required to cause necrosis 24 . However, this was a theoretical model, and the investigators did not consider the relative frailty of the seeded skeletal stem cells in loose impacted bone as opposed to native bone.
In our study 2, techniques to protect the cells from the curing cement did not produce a significant increase in cellular viability when compared with the positive controls, in either the allograft or the polymer group. It was hypothesized that precooling could potentially improve cell survival (1) if starting from a lower initial point would make it likely that the maximal temperature reached by the graft would be lower and hence fewer cells would perish and (2) a prestress to the cells could initiate the production of protective proteins (e.g., heat shock proteins), which can have protective effects in adverse conditions 25 . However, neither appeared to be the case; it is possible that the precooling treatment damaged the cells or that the time period chosen was not sufficient for the stimulation of the proteins. Furthermore, it is possible that an increased number of cells did survive the exposure but were not as active as the cells not subjected to precooling because they were in a different part of the cell cycle. It should also be noted that the cement-graft interface was affected by the precooling procedure, in that interdigitation was not as effective; hence, this method is not recommended.
Laponite is a novel smectite clay-gel that has been shown to support skeletal stem cells for ongoing proliferation and differentiation. In the clinical situation, it could potentially provide the cell nutrition required prior to host vascular ingrowth, reducing cell loss in tissue-engineered constructs 26 . It was hypothesized that precoating with this substance could also protect the cells via an insulation effect. However, there was a significant loss of cellular viability in all groups precoated with Laponite compared with the grafts exposed to the cement alone. It is possible that this additional loss of viability was a consequence of reduced effective gaseous exchange.
In conclusion, care is required when planning the incorporation of novel tissue-engineered constructs into well-established surgical procedures. The heat produced by polymerizing bone cement has the potential to denature proteins and kill or attenuate cells. In this model, exothermic effects were significant only within 0.5 cm of the cement-graft interface and were not sufficient to kill all cells in this region, leaving the potential for cell recolonization. This initial study indicates that the use of tissue-engineered constructs is not necessarily contraindicated in orthopaedic procedures (such as impaction bone-grafting) involving cement, although additional research is required to assess whether the continued viability and differentiation potential of the cells are affected.
